All‐cause death · patients with heart failure with sinus rhythm
Warfarin showed no clear difference in all‐cause death compared with placebo or no treatment (low certainty).
1 finding from 1 review
Stroke · patients with heart failure with sinus rhythm
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Major bleeding · patients with heart failure with sinus rhythm
Warfarin may leads to higher major bleeding eventsc compared with placebo or no treatment (low certainty).
1 finding from 1 review
All‐cause mortality · patients with heart failure with sinus rhythm
Summary of findings: warfarin showed no clear difference in all‐cause mortality compared with aspirin (moderate certainty).
1 finding from 1 review
Non‐fatal cardiovascular events · patients with heart failure with sinus rhythm
Summary of findings: warfarin showed no clear difference in non‐fatal cardiovascular events (non‐fatal stroke, myocardial… compared with aspirin (moderate certainty).
1 finding from 1 review
Major bleeding · patients with heart failure with sinus rhythm
Summary of findings: warfarin probably leads to higher major bleeding events compared with aspirin (moderate certainty).
1 finding from 1 review
All‐cause mortality · patients with heart failure with sinus rhythm
Summary of findings: warfarin showed no clear difference in all‐cause mortality compared with clopidogrel (low certainty).
1 finding from 1 review
Non‐fatal cardiovascular events · patients with heart failure with sinus rhythm
Summary of findings: warfarin showed no clear difference in non‐fatal cardiovascular events (non‐fatal stroke, myocardial… compared with clopidogrel (low certainty).
1 finding from 1 review
Major bleeding · patients with heart failure with sinus rhythm
Summary of findings: warfarin may leads to higher major bleeding events compared with clopidogrel (low certainty).
1 finding from 1 review